Merck Announces New Phase 3 Data on Weekly HIV Therapy
Merck announced new Phase 3 data on weekly HIV therapy with islatravir and lenacapavir.
Related stories
Oracle Announces $10 Million Stock and $10 Billion Bond Deals
Oracle shares fell after the company announced stock and bond deals.
M impact | EQUITY | Nov 02, 2026, 01:47 PM UTC
Fox Q1 results beat on advertising strength
Fox shares rose after the company reported Q1 results that beat expectations, citing advertising strength.
M impact | EQUITY | Nov 02, 2026, 01:45 PM UTC
Oracle-Aktien geben nach Ankündigung von Aktien- und Anleihegeschäften nach
Oracle-Aktien fallen nach Bekanntgabe von Aktiengeschäften im Wert von 10 Milliarden US-Dollar und Anleihegeschäften im Wert von 10 Milliarden US-Dollar.
L impact | EQUITY | Nov 02, 2026, 01:44 PM UTC
Navios Maritime Holdings Raises Tender Offer Price to $16, Extends Deadline
Navios Maritime Holdings increased the tender offer price and extended the expiration date for its cash offer to purchase Series G and Series H American Depositary Shares.
M impact | EQUITY | Nov 02, 2026, 01:44 PM UTC
Krystal Biotech Q3 Net Income Falls, Revenue Rises
M impact | EQUITY | Nov 02, 2026, 01:44 PM UTC
Infineon shares rise 3.6%
M impact | EQUITY | Nov 02, 2026, 01:43 PM UTC